Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 3496 AL 3510

Stereotypies: a critical appraisal and suggestion of a clinically useful definition

Edwards MJ, Lang AE, Bhatia KP.

Mov Disord. 2012 Feb;27(2):179-85. doi: 10.1002/mds.23994. Epub 2011 Dec 9.

The aging striatal dopamine function

Darbin O.

Parkinsonism Relat Disord. 2012 Jun;18(5):426-32. doi: 10.1016/j.parkreldis.2011.11.025. Epub 2011 Dec 15.

Sleep-related movement disorders

Merlino G, Gigli GL.

Neurol Sci. 2012 Jun;33(3):491-513. doi: 10.1007/s10072-011-0905-9. Epub 2011 Dec 28.

Functional brain networks and abnormal connectivity in the movement disorders

Poston KL, Eidelberg D.

Neuroimage. 2012 Oct 1;62(4):2261-70. doi: 10.1016/j.neuroimage.2011.12.021. Epub 2011 Dec 21.

The motor system and its disorders

Rowe JB, Siebner HR.

Neuroimage. 2012 Jun;61(2):464-77. doi: 10.1016/j.neuroimage.2011.12.042. Epub 2011 Dec 27.

Drug-induced movement disorders: emergencies and management

Robottom BJ, Shulman LM, Weiner WJ.

Neurol Clin. 2012 Feb;30(1):309-20, x. doi: 10.1016/j.ncl.2011.09.007. Epub 2011 Oct 11.

Successful stenting of a left main coronary artery occlusion as a complication of RF ablation for Wolff-Parkinson-White syndrome

Yalin K, Golcuk E, Bilge AK, Umman S, Adalet K.

Pacing Clin Electrophysiol. 2012 Feb;35(2):e43-6. doi: 10.1111/j.1540-8159.2010.02900.x. Epub 2010 Sep 30.

Advanced glycation endproducts and their pathogenic roles in neurological disorders

Münch G, Westcott B, Menini T, Gugliucci A.

Amino Acids. 2012 Apr;42(4):1221-36. doi: 10.1007/s00726-010-0777-y. Epub 2010 Oct 14.

Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome

Rabbani N, Thornalley PJ.

Amino Acids. 2012 Apr;42(4):1133-42. doi: 10.1007/s00726-010-0783-0. Epub 2010 Oct 21.

Current status and future directions of gene expression profiling in Parkinson's disease

Greene JG.

Neurobiol Dis. 2012 Jan;45(1):76-82. doi: 10.1016/j.nbd.2010.10.022. Epub 2010 Nov 5.

Role of tau kinases (CDK5R1 and GSK3B) in Parkinson's disease: a study from India

Das G, Misra AK, Das SK, Ray K, Ray J.

Neurobiol Aging. 2012 Jul;33(7):1485.e9-15. doi: 10.1016/j.neurobiolaging.2010.10.016. Epub 2010 Dec 3.

Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders

Bareggi SR, Cornelli U.

CNS Neurosci Ther. 2012 Jan;18(1):41-6. doi: 10.1111/j.1755-5949.2010.00231.x. Epub 2010 Dec 27.

Validity and reliability of the Geriatric Anxiety Inventory in Parkinson's disease

Matheson SF, Byrne GJ, Dissanayaka NN, Pachana NA, Mellick GD, O'Sullivan JD, Silburn PA, Sellbach A, Marsh R.

Australas J Ageing. 2012 Mar;31(1):13-6. doi: 10.1111/j.1741-6612.2010.00487.x. Epub 2010 Dec 29.

The effect of electromyographic biofeedback treatment in improving upper extremity functioning of patients with hemiplegic stroke

Doğan-Aslan M, Nakipoğlu-Yüzer GF, Doğan A, Karabay I, Özgirgin N.

J Stroke Cerebrovasc Dis. 2012 Apr;21(3):187-92. doi: 10.1016/j.jstrokecerebrovasdis.2010.06.006. Epub 2010 Sep 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias